Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
50.62
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,850
Open
50.62
Bid (Size)
51.17 (18)
Ask (Size)
51.20 (21)
Prev. Close
50.62
Today's Range
50.62 - 50.62
52wk Range
42.63 - 55.72
Shares Outstanding
1,250,690,553
Dividend Yield
3.76%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
July 21, 2024
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.
Via
Benzinga
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
July 17, 2024
European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed.
Via
Benzinga
Exposures
COVID-19
Performance
YTD
+1.24%
+1.24%
1 Month
+7.22%
+7.22%
3 Month
+7.36%
+7.36%
6 Month
-0.41%
-0.41%
1 Year
-6.12%
-6.12%
More News
Read More
Stable Blue-Chip Stocks to Buy Before Earnings Season
July 17, 2024
Via
InvestorPlace
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
July 16, 2024
Via
Benzinga
Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing
July 12, 2024
Via
Benzinga
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
July 11, 2024
Via
Benzinga
EXCLUSIVE: VeeCon 2024 Announces Danica Patrick, Jerome Bettis, Paul Scheer, Mike Posner, Liquid Death CEO Mike Cessario As New Speakers
July 11, 2024
Via
Benzinga
3 Stocks to Sell Immediately Based on the French Election Results
July 09, 2024
Via
InvestorPlace
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
Via
Investor's Business Daily
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Via
InvestorPlace
7 Safe Haven Stocks to Buy Before the Next Market Correction
July 03, 2024
Via
InvestorPlace
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
July 03, 2024
Via
Benzinga
Exposures
Product Safety
Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes
July 03, 2024
Via
InvestorPlace
Exposures
COVID-19
Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
July 02, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
July 01, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
July 01, 2024
Via
Benzinga
Where Will Novavax Be in 1 Year?
June 29, 2024
Via
The Motley Fool
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
June 27, 2024
Via
Benzinga
Exposures
Product Safety
Why Is Vigil Neuroscience (VIGL) Stock Up 32% Today?
June 27, 2024
Via
InvestorPlace
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
June 26, 2024
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Via
Benzinga
Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
June 20, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Is It Too Late to Buy Novavax Stock?
June 14, 2024
Via
The Motley Fool
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
June 13, 2024
Via
Investor's Business Daily
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
June 12, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.